- Clinical Significance and Natural History of "HBeAg Negativity" in Patients with Chronic HBV Infection
-
Lee YS
- KMID: 760639
- Korean J Hepatol.
- 2006 Jun;12(2):133-135.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients?
-
Kang K, Kim JH
- KMID: 2155334
- Korean J Gastroenterol.
- 2014 May;63(5):329-332.
- doi: 10.4166/kjg.2014.63.5.329
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Human Leukocyte Antigen Typing Proficiency Surveys in Korea, 2005-2006
-
Kim MH, Choi SE, Oh HB
- KMID: 1781549
- Korean J Lab Med.
- 2007 Dec;27(6):442-450.
- doi: 10.3343/kjlm.2007.27.6.442
BACKGROUND: To monitor the performance of histocompatibility testing laboratories, HLA proficiency survey in Korea has been conducted biannually since 1996. In this report, we summarized the results of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B
-
Kim JM, Choe BH, Chu MA, Cho SM
- KMID: 1381438
- Korean J Hepatol.
- 2009 Jun;15(2):168-178.
- doi: 10.3350/kjhep.2009.15.2.168
BACKGROUND/AIMS: The aim of this study was to establish the characteristics of children with hepatitis B e antigens (HBeAg) positive chronic hepatitis B who were cleared of hepatitis B surface... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Hepatitis B Surface Antigen Quantification in Chronic Hepatitis B
-
Yeon JE
- KMID: 2234033
- Korean J Gastroenterol.
- 2014 Jun;63(6):335-340.
- doi: 10.4166/kjg.2014.63.6.335
Since the discovery of HBsAg in the early 1960s, presence of HBsAg in serum has only served to diagnose hepatitis B. Recent development in the quantitative measurement of serum HBsAg... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay
-
Chung KH, Kim W, Kim BG, Lee HY, Jin E, Cho Y, Seo JY, Kim HY, Jung YJ, Kim JW, Jeong JB, Lee KL
- KMID: 2234073
- Gut Liver.
- 2015 Sep;9(5):657-664.
- doi: 10.5009/gnl14188
BACKGROUND/AIMS: Quantification of hepatitis B surface antigen (HBsAg) is an emerging serologic test and may be useful for identifying treatment strategies for chronic hepatitis B (CHB). This study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B
-
Cho YK, Song BC
- KMID: 1128352
- Korean J Gastroenterol.
- 2011 Mar;57(3):144-149.
- doi: 10.4166/kjg.2011.57.3.144
Over the past decade, advances in the antiviral therapy in patients with chronic hepatitis B have enabled the sustained suppression of hepatitis B viral replication and the prevention of progressive... -
- CITED
-
- Close
- SHARE
-
- Close
- Shifting in Seroprevalence of HBsAg and Anti-HCV during Recent 10 Years in Adults Resident in Daegu and Gyeongbuk Province
-
Lee KI, Park KS, Seo HJ, Kim TY, Kim ES, Jang BK, Chung WJ, Cho KB, Hwang JS
- KMID: 1718414
- Korean J Gastroenterol.
- 2011 Aug;58(2):82-87.
- doi: 10.4166/kjg.2011.58.2.82
BACKGROUND/AIMS: There have been only few studies on the population-adjusted seroprevalence of HBV and HCV and on the change of them for more than 10 years in Korea. Therefore, this... -
- CITED
-
- Close
- SHARE
-
- Close
- Measurement of IgE and IgG subclass antibodies to whole body antigen and two major allergens (Der fI & Der fII) of Dermatophagoides farinae in normal subjects and asthmatics
-
Hong CS, Park JW, Nahm DH
- KMID: 1125984
- Yonsei Med J.
- 1994 Dec;35(4):453-463.
- doi: 10.3349/ymj.1994.35.4.453
House dust mites have been known as the most important allergen in respiratory allergic diseases. Among several mite allergens, group I and group II antigens were recognized as major allergens.... -
- CITED
-
- Close
- SHARE
-
- Close
- Inactive hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study
-
Demirturk , Demirdal T
- KMID: 1737599
- Clin Mol Hepatol.
- 2014 Mar;20(1):56-60.
- doi: 10.3350/cmh.2014.20.1.56
BACKGROUND/AIMS: The aims of the present study were to determine the outcomes of inactive hepatitis B virus (HBV) surface antigen (HBsAg) carriers over a 10-year study period and to elucidate... -
- CITED
-
- Close
- SHARE
-
- Close
- HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
-
Kim JH, Choi YJ, Moon HW, Ko SY, Choe WH, Kwon SY
- KMID: 1730887
- Clin Mol Hepatol.
- 2013 Dec;19(4):409-416.
- doi: 10.3350/cmh.2013.19.4.409
BACKGROUND/AIMS: Quantification of the hepatitis B surface antigen (HBsAg) is increasingly used to determine the treatment response in patients with chronic hepatitis B (CHB). However, there are limited data about... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
-
Kim JH, Moon HW, Ko SY, Choe WH, Kwon SY
- KMID: 2069764
- Clin Mol Hepatol.
- 2014 Sep;20(3):274-282.
- doi: 10.3350/cmh.2014.20.3.274
BACKGROUND/AIMS: Quantitation of hepatitis B surface antigen (HBsAg) is an increasingly popular method to determine the treatment response in chronic hepatitis B (CHB) patients. The clinical value of HBsAg level... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison Study with Enzyme Immunoassay and Chemiluminescence Immunoassay for Hepatitis B Virus Surface Antigen Detection
-
Huh HJ, Chae SL, Cha YJ
- KMID: 1781535
- Korean J Lab Med.
- 2007 Oct;27(5):355-359.
- doi: 10.3343/kjlm.2007.27.5.355
BACKGROUND: The serological detection of the surface antigen (HBsAg) of hepatitis B virus (HBV) is the basis of detection of HBV infections in blood donors and patients with hepatitis.... -
- CITED
-
- Close
- SHARE
-
- Close
- Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B
-
Song JC, Min BY, Kim JW, Kim JY, Kim YM, Shin CM, Lee SH, Hwang JH, Jeong SH, Kim N, Lee DH
- KMID: 1792605
- Korean J Hepatol.
- 2011 Dec;17(4):268-273.
- doi: 10.3350/kjhep.2011.17.4.268
BACKGROUND/AIMS: Decay of hepatitis B surface antigen (HBsAg) titers has previously been shown to be predictive of a virologic response (VR), especially during peginterferon-alpha therapy. However, the role of HBsAg... -
- CITED
-
- Close
- SHARE
-
- Close
- Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
-
Song BC, Cho YK, Jwa H, Choi EK, Kim HU, Song HJ, Na SY, Boo SJ, Jeong SU
- KMID: 2070253
- Clin Mol Hepatol.
- 2014 Dec;20(4):355-360.
- doi: 10.3350/cmh.2014.20.4.355
BACKGROUND/AIMS: Spontaneous HBeAg seroconversion occurs frequently in the immune reactive phase in HBeAg-positive chronic hepatitis B (CHB). Therefore, observation for 3-6 months before commencing antiviral therapy is recommended in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Pre- and Post-transfusion Testing for Hepatitis B Virus Surface Antigen and Antibody in Blood Recipients: A Single-Institution Experience in an Area of High Endemicity
-
Kim H, Hur M, Moon HW, Park CM, Cho JH, Park KS, Lee K, Chang S
- KMID: 1781441
- Ann Lab Med.
- 2012 Jan;32(1):73-78.
- doi: 10.3343/alm.2012.32.1.73
BACKGROUND: Hepatitis B remains the most common transfusion-transmitted viral infection. We explored the current status of pre-transfusion screening and post-transfusion follow-up testing for hepatitis B virus (HBV) surface antigen (HBsAg)... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum ALT and HBV DNA Levels in Patients with HBeAg-Negative Chronic Hepatitis B
-
Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M
- KMID: 1085301
- Korean J Hepatol.
- 2003 Dec;9(4):284-292.
BACKGROUND/AIMS: HBeAg-negative chronic hepatitis B (CHB) has a poor long-term prognosis. Since no precise clinically relevant HBV thresholds are known in HBeAg-negative CHB, the decision to treat is difficult.... -
- CITED
-
- Close
- SHARE
-
- Close
- Natural History of HBeAg Negative Chronic Hepatitis B Virus Infection: A Cohort Study
-
Moon CM, Kim DY, Song KJ, Kim JK, Lee HW, Lee JM, Yoon KT, Paik YH, Kim DK, Han KH, Chon CY, Moon YM, Ahn SH
- KMID: 760643
- Korean J Hepatol.
- 2006 Jun;12(2):163-172.
BACKGROUND/AIMS: The long-term virologic and biochemical changes in patients with HBeAg negative HBV infection, especially in Asia, remain unclear. To address this issue, we conducted a 3 year- retrospective,... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes of Clevudine versus Lamivudine at Week 48 in Naive Patients with HBeAg Positive Chronic Hepatitis B
-
Kim IH, Lee S, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Choi CS, Kim HC
- KMID: 1713959
- J Korean Med Sci.
- 2010 May;25(5):738-745.
- doi: 10.3346/jkms.2010.25.5.738
The authors assessed the efficacy and antiviral resistance of 48-week clevudine therapy versus lamivudine in treatment of naive patients with HBeAg positive chronic hepatitis B. In this retrospective study, a... -
- CITED
-
- Close
- SHARE
-
- Close
- Higher Seroprevalence of Hepatitis B Virus Antigen in Patients with Cystic Hydatid Disease than in Patients Referred to Internal Medicine Clinics in Turkey
-
Gultepe B, Dulger AC, Gultepe I, Karadas S, Ebinc S, Esen R
- KMID: 1715670
- Korean J Parasitol.
- 2014 Feb;52(1):47-49.
- doi: 10.3347/kjp.2014.52.1.47
Turkey remains an intermediate area for prevalence of hepatitis B virus (HBV) surface antigenemia. The sheep-raising areas of Turkey also pose a high risk for cystic hydatid disease (CHD). Both... -
- CITED
-
- Close
- SHARE
-
- Close
